Boston Scientific seeks EU clearance for $14.5bn Penumbra deal
By Nicholas Hirst and Jean Comte ( October 29, 2026, 14:11 GMT | Insight) -- Boston Scientific has asked the EU merger regulator to approve its $14.5 billion acquisition of rival US biomedical company Penumbra. The European Commission has set a deadline of Dec. 4 to either approve the deal or open an in-depth inquiry, although that deadline could slip if the company offers concessions.Boston Scientific has requested EU approval for its acquisition of Penumbra, according to an update on the European Commission website. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.